Side effects seen with use of chloroquine against COVID-19

Side effects seen with use of chloroquine against COVID-19

(HealthDay)—The use of the antimalarial drug chloroquine to treat COVID-19 patients has been halted at several Swedish hospitals due to reported side effects such as cramps and loss of peripheral vision. Sahlgrenska University Hospital is one of those facilities. It stopped the use of chloroquine in the treatment of COVID-19 about two weeks ago.

"There were reports of suspected more serious than we first thought," Magnus Gisslen, M.D., Ph.D., a professor and chief physician at Sahlgrenska University Hospital infection clinic, told the Gothenburg Post on April 1, Newsweek reported. "We cannot rule out , especially from the heart, and it is a hard-dosed drug. In addition, we have no strong evidence that chloroquine has an effect on COVID-19."

No specific drugs are used to treat COVID-19, but some people have advocated the use of the antimalarial drugs chloroquine and hydroxychloroquine. U.S. President Donald Trump has touted the use of hydroxychloroquine in particular and announced Sunday that the had stockpiled 29 million hydroxychloroquine pills for the treatment of COVID-19, Newsweek reported.

The use of hydroxychloroquine to treat COVID-19 was approved last month by the U.S. Food and Drug Administration, even though scientific studies of the two antimalarial drugs have yielded mixed results, Newsweek reported.

As of Tuesday afternoon, there were 383,256 COVID-19 cases and more than 12,000 deaths reported in the United States, according to Johns Hopkins University.


Explore further

Use malaria drugs only for virus emergencies: EU agency

More information: Newsweek Article
Johns Hopkins University

Copyright © 2020 HealthDay. All rights reserved.

Citation: Side effects seen with use of chloroquine against COVID-19 (2020, April 8) retrieved 30 May 2020 from https://medicalxpress.com/news/2020-04-side-effects-chloroquine-covid-.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
3 shares

Feedback to editors

User comments